Impact of Betamethasone on preterm infants outcomes
Phase 3
- Conditions
- Respiratory distress syndrome of newborn.Hyaline membrane disease
- Registration Number
- IRCT2014090912789N6
- Lead Sponsor
- Vice Chancellor for Research, Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Inclusion criteria were singleton pregnancy and gestational age 26- 34 weeks Exclusion criteria included: allergy to Betamethasone, history of any maternal systemic disorders like hypertension, diabetes, liver and cardiac disease, renal failure, neoplasia and cervical dilation > 5 cm.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Respiratory distress syndrome. Timepoint: Every day up to 28 days after birth. Method of measurement: sign and symptoms of Respiratory distress syndrome diagnosed by pediatrician.
- Secondary Outcome Measures
Name Time Method Intraventricular Hemorrhage. Timepoint: Every day up to 28 days after birth. Method of measurement: Clinical examination by pediatrician.;Infant Death. Timepoint: Every day up to 28 days after birth. Method of measurement: Based on neonatologist diagnosis.;Necrotizing enterocolitis. Timepoint: Every day up to 28 days after birth. Method of measurement: Clinical examination by pediatrician.